Redox stress resilience in aging skeletal muscle
衰老骨骼肌的氧化还原应激恢复能力
基本信息
- 批准号:10722970
- 负责人:
- 金额:$ 48.54万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-01 至 2025-08-31
- 项目状态:未结题
- 来源:
- 关键词:AblationAcuteAgeAgingAnimal FeedAntioxidantsAttenuatedAutomobile DrivingBindingBiologicalCellsCessation of lifeChronicCommunicationCytoplasmDevelopmentDietDiseaseDoxycyclineEquilibriumExerciseFunctional disorderFutureGene ExpressionGenetic ModelsHomeostasisHumanImpairmentIndividualKnowledgeMAP Kinase GeneMeasuresMessenger RNAMitochondriaModelingMolecularMusMuscleMuscle ContractionMuscle functionOrganOrganismOxidantsOxidation-ReductionPathologicPathologyPathway interactionsPhosphotransferasesPhysiologicalProcessProductionProteinsProteomeQuality of lifeReactive Oxygen SpeciesResearchResolutionResourcesRestRiskRoleSOD2 geneSignal InductionSignal TransductionSkeletal MuscleSourceStressStress Response SignalingSulfhydryl CompoundsTestingTimeTissuesTransgenic OrganismsWild Type MouseWorkacute stressage relatedagedbiological adaptation to stresscellular resilienceclinically significantexperimental studyfunctional declinefunctional improvementhabituationhealthspanimprovedin vivoinsightknock-downloss of functionmitochondrial dysfunctionmouse modelmuscle agingnoveloxidant stressoxidationp38 Mitogen Activated Protein Kinasepharmacologicphysiologic stressorpoor health outcomeprotein expressionresilienceresponsesmall hairpin RNAstress resiliencestressortooltranscription factor
项目摘要
PROJECT SUMMARY/ABSTRACT
Aging is associated with impaired stress resilience defined as a loss of the ability of cells, organs, and organisms
to adapt to physiological or pathological stressors. Evidence suggests that this loss of resilience arises before
any overt pathology, and eventually contributes to the loss of function, disease, and death. However, the cellular
mechanisms that drive this process are poorly understood. For cells to adapt to environmental and endogenous
stressors they need to be able to communicate the stress signal through signal transduction mechanisms.
However, for transient stress signals to be effective, they should be low under resting conditions. The
transcription factor Nrf2 activates early changes in gene expression to enhance redox and energetic adaptations
in response to acute redox stress associated with muscle contraction. In healthy individuals this leads to an
adaptive response to restore redox balance and increased cellular resilience to future stresses. Nrf2 is
chronically activated under basal conditions and has an attenuated response to muscle contraction in human
aged skeletal muscle. In addition, aging is associated with elevated reversible oxidation of the thiol proteome, a
primary signal transduction mechanism driving redox adaptation, and that reducing mitochondrial redox stress
restores the thiol proteome to that found in young. Here we test the hypothesis that mitochondrial redox stress
in aging muscle is the chronic low-level stress that impairs the signal transduction communication in the cell
underlying the impaired redox stress response to muscle contraction. This research uses skeletal muscle
contraction as a model to generate new insights into the molecular mechanisms underlying reduced resilience
with age. Aim 1 tests whether increasing mitochondrial redox stress is sufficient to drive declining muscle function
and adaptive stress response signaling to acute muscle contraction by characterizing a novel SOD2 Knockdown
mouse model and layering this knockdown to measure redox stress response signaling. Aim 2 tests whether
decreasing mitochondrial or cytoplasmic redox stress is sufficient to restore adaptive stress response signaling
to acute muscle contraction by treating young and old wild type mice as well as mice iSOD2 KD mice with
mitoTEMPO or TEMPO as mitochondrial targeted antioxidant vs a non targeted antioxidant. Results from the
proposed experiments will significantly impact the field by elucidating redox stress response signaling in aging
and age-related muscle/mitochondrial dysfunction. These results will have clear clinical significance as there are
already several mitochondrially targeted pharmacological compounds that are redox active and can be tested in
humans.
项目概要/摘要
衰老与应激恢复能力受损有关,应激恢复能力被定义为细胞、器官和生物体能力的丧失
适应生理或病理应激源。有证据表明,这种弹性丧失发生在
任何明显的病理,并最终导致功能丧失、疾病和死亡。然而,蜂窝
人们对驱动这一过程的机制知之甚少。使细胞适应环境和内源性
他们需要能够通过信号转导机制传达压力信号。
然而,为了使瞬态压力信号有效,它们在休息条件下应该很低。这
转录因子 Nrf2 激活基因表达的早期变化,以增强氧化还原和能量适应
响应与肌肉收缩相关的急性氧化还原应激。在健康个体中,这会导致
恢复氧化还原平衡并增强细胞对未来压力的适应能力的适应性反应。 Nrf2 是
在基础条件下长期激活,对人体肌肉收缩的反应减弱
老化的骨骼肌。此外,衰老与硫醇蛋白质组的可逆氧化升高有关,硫醇蛋白质组是一种
驱动氧化还原适应并减少线粒体氧化还原应激的主要信号转导机制
将硫醇蛋白质组恢复到年轻人的水平。在这里我们检验线粒体氧化还原应激的假设
老化肌肉中的慢性低水平压力会损害细胞内的信号转导通讯
肌肉收缩的氧化还原应激反应受损。这项研究使用骨骼肌
收缩作为模型,可以对弹性降低的分子机制产生新的见解
随着年龄的增长。目标 1 测试增加线粒体氧化还原应激是否足以驱动肌肉功能下降
通过表征新型 SOD2 敲低来向急性肌肉收缩发出适应性应激反应信号
小鼠模型并对这种敲低进行分层以测量氧化还原应激反应信号。目标 2 测试是否
减少线粒体或细胞质氧化还原应激足以恢复适应性应激反应信号
通过治疗年轻和年老的野生型小鼠以及 iSOD2 KD 小鼠来治疗急性肌肉收缩
mitoTEMPO 或 TEMPO 作为线粒体靶向抗氧化剂与非靶向抗氧化剂。结果来自
拟议的实验将通过阐明衰老过程中的氧化还原应激反应信号来对该领域产生重大影响
和与年龄相关的肌肉/线粒体功能障碍。这些结果将具有明确的临床意义,因为
已经有几种靶向线粒体的药理化合物具有氧化还原活性,可以在
人类。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
David J. Marcinek其他文献
Time-restricted feeding improves aortic endothelial relaxation by enhancing mitochondrial function and attenuating oxidative stress in aged mice
限时喂养通过增强线粒体功能和减轻老年小鼠的氧化应激来改善主动脉内皮松弛
- DOI:
- 发表时间:
2024 - 期刊:
- 影响因子:11.4
- 作者:
Madison Milan;Jacob Brown;Colleen L. O’Reilly;Matthew Bubak;Sharon Negri;Priya Balasubramanian;A. Dhanekula;Gavin A. Pharaoh;Zeke Reyff;Cade Ballard;Helen Shi;A. Yabluchanskiy;Mike Rudolph;Z. Ungvari;David J. Marcinek;Benjamin F. Miller;Holly Van Remmen;S. Tarantini - 通讯作者:
S. Tarantini
David J. Marcinek的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('David J. Marcinek', 18)}}的其他基金
Increased Risk of Chronic Disease Due to Domoic Acid Exposure with Age
随着年龄的增长,软骨藻酸暴露导致慢性病的风险增加
- 批准号:
10438785 - 财政年份:2018
- 资助金额:
$ 48.54万 - 项目类别:
Increased Risk of Chronic Disease Due to Domoic Acid Exposure with Age
随着年龄的增长,软骨藻酸暴露导致慢性病的风险增加
- 批准号:
10205069 - 财政年份:2018
- 资助金额:
$ 48.54万 - 项目类别:
Increased Risk of Chronic Disease Due to Domoic Acid Exposure with Age
随着年龄的增长,软骨藻酸暴露导致慢性病的风险增加
- 批准号:
9702219 - 财政年份:2018
- 资助金额:
$ 48.54万 - 项目类别:
Preventing Skeletal and Cardiac Muscle Aging by Restoring Mitochondrial Function
通过恢复线粒体功能预防骨骼肌和心肌老化
- 批准号:
9564597 - 财政年份:2017
- 资助金额:
$ 48.54万 - 项目类别:
SS peptides: a new approach to improve mitochondrial and skeletal muscle function
SS 肽:改善线粒体和骨骼肌功能的新方法
- 批准号:
8444893 - 财政年份:2012
- 资助金额:
$ 48.54万 - 项目类别:
SS peptides: improve mitochondrial and skeletal muscle function with age
SS肽:随着年龄的增长改善线粒体和骨骼肌功能
- 批准号:
8554758 - 财政年份:2012
- 资助金额:
$ 48.54万 - 项目类别:
Mitochondrial function, oxidative damage, and aging
线粒体功能、氧化损伤和衰老
- 批准号:
6870808 - 财政年份:2005
- 资助金额:
$ 48.54万 - 项目类别:
Mitochondrial function, oxidative damage, and aging
线粒体功能、氧化损伤和衰老
- 批准号:
7198108 - 财政年份:2005
- 资助金额:
$ 48.54万 - 项目类别:
Mitochondrial function, oxidative damage, and aging
线粒体功能、氧化损伤和衰老
- 批准号:
7369717 - 财政年份:2005
- 资助金额:
$ 48.54万 - 项目类别:
Mitochondrial fuction, oxidative damage, and aging
线粒体功能、氧化损伤和衰老
- 批准号:
7022219 - 财政年份:2005
- 资助金额:
$ 48.54万 - 项目类别:
相似国自然基金
剪接因子U2AF1突变在急性髓系白血病原发耐药中的机制研究
- 批准号:82370157
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
IKZF1-N159Y/S热点突变在急性白血病中的致病机制研究
- 批准号:82300168
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
NMNAT1上调B7-H3介导急性早幼粒细胞白血病免疫逃逸的作用和机制研究
- 批准号:82300169
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
支链氨基酸转氨酶1在核心结合因子急性髓细胞白血病中的异常激活与促进白血病发生的分子机制研究
- 批准号:82370178
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
SRSF3/LRP5/Wnt信号通路在急性淋巴细胞白血病中的作用及机制研究
- 批准号:82370128
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Role of oligodendrocyte-derived IL-33 in brain aging and Alzheimer's disease
少突胶质细胞来源的 IL-33 在大脑衰老和阿尔茨海默病中的作用
- 批准号:
10736636 - 财政年份:2023
- 资助金额:
$ 48.54万 - 项目类别:
A Novel VpreB1 Anti-body Drug Conjugate for the Treatment of B-Lineage Acute Lymphoblastic Leukemia/Lymphoma
一种用于治疗 B 系急性淋巴细胞白血病/淋巴瘤的新型 VpreB1 抗体药物偶联物
- 批准号:
10651082 - 财政年份:2023
- 资助金额:
$ 48.54万 - 项目类别:
Dissecting the complex role of microglia states in glaucoma
剖析小胶质细胞状态在青光眼中的复杂作用
- 批准号:
10650571 - 财政年份:2023
- 资助金额:
$ 48.54万 - 项目类别:
Defining The Role of Failed-Repair Proximal Tubule Cells in AdvancedRenal Disease in African Americans
确定修复失败的近端小管细胞在非裔美国人晚期肾病中的作用
- 批准号:
10740665 - 财政年份:2023
- 资助金额:
$ 48.54万 - 项目类别:
Astrocyte regulation of cerebral blood flow at the intersection of ischemia and Alzheimer's disease
星形胶质细胞对缺血和阿尔茨海默病交叉点脑血流的调节
- 批准号:
10774128 - 财政年份:2023
- 资助金额:
$ 48.54万 - 项目类别: